Day: April 8, 2021

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign. In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to...

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Barrick will release its Q1 2021 results on Wednesday, May 5, 2021. President and CEO Mark Bristow will host a virtual presentation on the results that day at 11:00 EDT, with an interactive webinar linked to a conference call. Participants will be able to ask questions. The company will release its preliminary production, sales and cost information for Q1 2021 on April 15, 2021.Release of Q1 preliminary production, sales and cost informationApril 15, 07:00 EDT / 11:00 UTCQ1 RESULTS ANNOUNCEMENTQ1 Results releaseMay 5, 06:00 EDT / 10:00 UTC Q1 Results webinarMay 5, 11:00 EDT / 15:00 UTCGo to the webinar Conference call linked to webinarMay 5, 11:00 EDT / 15:00 UTC US/Canada (toll-free), 1 800 319 4610UK (toll-free), 0808 101 2791International (toll), +1 416 915 3239The webinar will...

Selskabsmeddelelse nr. 68 af 8. april 2021, der indeholder Intern Viden. Offentliggørelse af Årsrapport 2020 og ændringer, præciseringer og tilbagekaldelse af tidligere udsendte Selskabsmeddelelser. Det finansielle resultat i denne Selskabsmeddelelse relaterer til Waturu Holding A/S, som sammen med Waturu ApS, Aquaturu A/S, Aquaturu Denmark ApS, og Watgen Medical A/S udgør alle Waturu Holding koncernens aktiviteter. Den fulde årsrapport bliver tilgængelig på http://www.waturu.dk/dokumenter d. 9. april 2021. Koncernregnskabet og regnskabstal for de respektive selskaber der indgår i koncernen er baseret på låste tal der har været genstand for revision. De låste tal er grundlag for den igangværende færdiggørelse af koncernens årsrapporter, hvor færdiggørelsen alene er af redaktionel karakter – idet den talmæssige behandling og gennemgang...

WINNIPEG, Manitoba, 08 avr. 2021 (GLOBE NEWSWIRE) — The North West Company Inc. (l’« Entreprise » ou « North West ») a annoncé aujourd’hui un plan pour la transition de son ancien à son nouveau chef de la direction, présenté ses résultats financiers non vérifiés pour le quatrième trimestre terminé le 31 janvier 2021 et publié son rapport annuel 2020 et sa notice annuelle. Le rapport annuel inclut les états financiers consolidés annuels vérifiés de l’entreprise ainsi que le rapport de gestion pour l’exercice clos le 31 janvier 2021. Ces documents peuvent être consultés sur le profil de l’entreprise sur le site Web de SEDAR à l’adresse www.sedar.com ainsi que sur le site Web de North West à l’adresse www.northwest.ca. L’Entreprise a également annoncé que le conseil d’administration...

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) — Honey Badger Silver Inc. (TSX-V: TUF) (“Honey Badger Silver” or the “Company”) is pleased to announce that it has engaged Sharechest™ Inc., an innovative proprietary technology company that empowers issuers to use their existing on-line presence to streamline and simplify communications between management and investors. As an example, investors that are interested in connecting with Honey Badger Silver on matters relating to its current ‘live’ flow-through financing of $1.5 million previously announced (see press release of March 9, 2021) may do so through the Sharechest Connector on Honey Badger’s website, www.honeybadgersilver.com. For further information on Sharechest, please visit www.sharechest.io. Chad Williams is a director and shareholder of Sharechest™ Inc. For more information,...

Combination Creates the Most Expansive, Fully Integrated Cannabis Business in the World’s Largest Cannabis Market Long-term Cultivation Expansion to 6 Million ft2of State-of-the-Art Greenhouse Represents by Far the Largest Capacity of Any Cannabis Operator in California Retail Footprint Expected to Reach 21 Operational Dispensaries by Q1 2022, More Than Double the Next Largest Retail Operator Current Brand Portfolio Includes Glass House Farms – the #2 Ranked Flower Brand in California (YE2020 per BDS Analytics), as well as Forbidden Flowers and Mama Sue Total Purchase Price Consideration of US$567 Million Represents a 2022E Revenue and Adjusted EBITDA Multiple of 1.7x and 5.5x, Respectively Investors Commit to US$85 Million Private Placement; Combined Public Company Expected to Have up to $US355 Cash Balance at Closing Joint Conference...

NEWARK, Del., April 08, 2021 (GLOBE NEWSWIRE) — Artesian Resources Corporation (NASDAQ: ARTNA), a leading provider of water, wastewater services and related services on the Delmarva Peninsula today announced that its 2020 Annual Report is available electronically to shareholders through its website at https://www.artesianwater.com/investor-relations/annual-report/. If any shareholder would like to receive a print copy of the 2020 Annual Report, they can request one free of charge by writing or calling Artesian Resources Corporation, 664 Churchmans Road, Newark, Delaware 19702, Attention Laura Slayman (Phone Number: 302-453-6900). About Artesian Resources Artesian Resources Corporation operates as a holding company of wholly-owned subsidiaries offering water and wastewater services, and related services, on the Delmarva Peninsula....

VANCOUVER, Washington, April 08, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with potential multiple therapeutic indications, announced today its COVID-19 long-haulers study (“CD15”) is now fully enrolled. Enrollment was faster than expected because of the high number of patients wanting to participate, which now includes 56 patients in the trial. This is a multicenter Phase 2, two-arm, randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of Vyrologix™ (leronlimab) in the treatment of patients with prolonged COVID-19 symptoms, a condition now known as Post-Acute COVID Syndrome (PACS). Patients will be given eight (8) weekly doses of Vyrologix™ or placebo. The final treatment...

369 g/t Au sur 3,5 mètres dans Lynx 155 g/t Au sur 3,0 mètres dans Triple Lynx TORONTO, 08 avr. 2021 (GLOBE NEWSWIRE) — Minière Osisko inc. (OSK : TSX, « Osisko » ou la « Société ») a le plaisir de publier de nouveaux résultats d’analyse issus du programme de forage en cours sur le projet aurifère Windfall, entièrement détenu par la Société et situé dans la ceinture de roches vertes de l’Abitibi, dans le canton d’Urban, Eeyou Istchee Baie-James, Québec. Les nouveaux résultats d’analyse significatifs présentés ci-dessous comprennent 78 intervalles dans 46 sondages (12 à partir de la surface, 22 sous terre) et 12 déviations. Les intersections intercalaires sont situées à l’intérieur des blocs définis dans le cadre de l’estimation des ressources minérales de février 2021 (l’« ERM ») (voir le communiqué d’Osisko publié le 17 février...

CALGARY, Alberta and VICTORIA, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) — CE Brands Inc. (TSXV:CEBI.P, “CEBI”) and eBuyNow eCommerce Ltd. (“EBN”) are pleased to announce that shareholders have overwhelmingly approved all matters relating to CEBI’s proposed acquisition of EBN (the “Proposed Transaction”). The Proposed Transaction is intended to constitute CEBI’s Qualifying Transaction within the meaning of TSX Venture Exchange policies. CEBI and EBN are also pleased to announce that they have made further amendments to the Amalgamation Agreement dated March 12, 2020, to require that gross proceeds of not less than $10,000,000 must be raised under CEBI’s prospectus offering of subscription receipts (the “Public Offering”), which was announced on February 10, 2021. Previously, the Amalgamation Agreement required that gross...